NHS-Galleri Linked to Delays - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

NHS-Galleri Linked to Delays

Analysis of England’s multicancer early detection screening trial found modest, temporary diagnostic delays in participating regions, adding to concerns about health system effects and the evidence base for population-level blood-based cancer screening.

  • By

  • Andrea Surnit

  • June 4, 2026

  • 6 min

Share

Objective:

To evaluate the impact of participation in the NHS-Galleri trial on diagnostic delay rates for suspected head and neck, lung, and upper gastrointestinal cancers.

Key Findings:
  • Diagnostic delay rates increased from 29% to 30% in participating regions and decreased from 29% to 26% in nonparticipating regions during the first 6 months.
  • Participation in the trial was associated with an approximately 3-percentage-point increase in diagnostic delay rates.
  • The estimated increase in delayed referrals during the first year was 9,591.
  • Average time to diagnostic resolution increased by about 2 days in participating regions.
Interpretation:

Limitations:
  • Participating regions had greater socioeconomic deprivation and fewer healthcare staff than nonparticipating regions, raising the possibility of residual confounding.
  • Only 6 months of pretrial data were available to assess baseline trends.
  • The data could not distinguish between referrals that resulted in cancer diagnosis and those in which cancer was ruled out.
Conclusion:

Original Source(s)

NHS-Galleri Linked to Delays

  • by Andrea Surnit

  • June 4, 2026

Related Content

Narrow DCIS Margins May Not Always Warrant Reexcision

An ancillary analysis found less than 2-percentage-point differences in 10-year recurrence across margin thresholds, with no statistically significant adjusted association.

When Bad Data Enters the Drug Pipeline

Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.

New CDC Report Tracks US Mortality Trends

The annual provisional report summarizes changes in mortality rates, demographic patterns, and leading causes of death during 2025.